Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C
Clinical trial NCT01903278 · COMPLETED
Trial details
- NCT number
- NCT01903278
- Sponsor
- Beijing Kawin Technology Share-Holding Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2015-08-01
- Enrollment
- 719
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.